Academic detailing definition

Academic detailing means the provision of information regarding prescription drugs based on scientific and medical research, including information on therapeutic and cost-effective use of prescription drugs.[PL 2007, c. 327, §1 (NEW).]
Academic detailing is another means of communicating best practices in cost-effective drug prescribing. It was developed to provide physicians with unbiased information to counterbalance that delivered by sales representatives from pharmaceutical manufacturers (commonly known as drug detailers). It consists of a review, carried out by pharmacists headquartered in a hospital

Examples of Academic detailing in a sentence

  • Academic detailing improves identification and reporting of adverse drug events.

  • Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center.

  • Academic detailing to improve laboratory testing among outpatient medication users.Med Care.

  • Legal Advantages of Academic DetailingAs shown in Sorrell, Vermont’s attempt to suppress the free flow of prescriber-identifying data to pharmaceutical detailers was impermissible under the First Amendment.220 Academic detailing, on the other hand, can sufficiently achieve many of the same policy goals, such as contain- ing prescription drug costs and promoting public health, with no legal interference.

  • Chapter VII Special Provisions relating to Environmental Impact Assessments and Other Procedures Section 2.

  • Academic detailing statistics on Fall prevention and management (Excel spreadsheet data).

  • Academic detailing or educational outreach, a face-to-face encounter between the detailer and the prescriber with the aim of transferring unbiased information,11 has been shown to be effective in modifying physicians' prescribing behaviors12,13.

  • The term “academic detailing” reflects this hybrid concept.75 Academic detailing programs and other portals for dissemination of medical information are growing in number.76 Recent evidence indicates that physicians are willing to participate in such programs to improve patient care.77 In general, these programs work by sending a pharmacist, nurse or doctor (known as a “detailer”) to visit a physician’s office, just as industry would.

  • Funds will be used to support academic detailing to educate and build provider capacity to deliver HCV screening, linkage to care activities within health care settings.Rational for proposed new activities: Academic detailing is a structured visit by trained personnel to health care practices for the purpose of delivering tailored training and technical assistance to health care providers to help them incorporate best practice into clinical care.

  • Academic detailing is a process by which a health educator visits a doctor in his/her office to provide a 15to 20 minute educational presentation on a particular topic.

Related to Academic detailing

  • Research Use shall have the meaning given in Section 2.2.2 of this Agreement.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Academic year means the period of twelve months beginning on 1st January, 1st April, 1st July or 1st September according to whether the course in question begins in the winter, the spring, the summer or the autumn respectively but if students are required to begin attending the course during August or September and to continue attending through the autumn, the academic year of the course is to be considered to begin in the autumn rather than the summer;

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Development Application means the development application identified in Item 5 of Schedule 1 and includes all plans, reports models, photomontages, material boards (as amended supplemented) submitted to the consent authority before the determination of that Development Application.

  • Commercializing means to engage in Commercialization and “Commercialized” has a corresponding meaning.

  • Research Results means any technical result acquired based on the Collaborative Research, including, but not limited to, any invention, idea, design, copyrightable work and know-how which relates to the purpose of the Collaborative Research.

  • Collaboration has the meaning set forth in Section 2.1.

  • Companion Diagnostic means a device which is essential for the safe and effective use of a corresponding medicinal product to:

  • Commercial Product means any such product as defined in FAR 2.101.

  • Licensed Nurse means an Oregon licensed practical or registered nurse.

  • Royalty Product means, either (a) an Alnylam Royalty Product, or (b) an Inex Royalty Product.

  • Development Tool Kit means a DS Offering specifically designed for application or content development. A Development Tool Kit is either identified (i) with “CAA” or “ENOVIA Studio” in the DS Offering name, or (ii) in the Transaction Document and/or the Product Portfolio. Extended Enterprise User means an employee of Customer’s affiliate(s), supplier(s) and/or customer(s) authorized to use Customer’s DS Offering for the sole and exclusive purpose of enabling the Extended Enterprise User(s) to conduct business with Customer. The use of the DS Offering by any such Extended Enterprise User(s) 1) shall be solely limited to use (a) as configured and deployed by Customer and (b) in connection with the Extended Enterprise User’s performance of services for and on behalf of Customer, and 2) shall exclude any use by Extended Enterprise User (a) for its own account or a third party’s account, or (b) for the purpose of modifying, otherwise using, maintaining or hosting the DS Offering. Extended Enterprise Users are authorized if so specified in the Product Portfolio.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Development Tools means the development kits, programming tools, emulators and other materials that may be used in the development of Games under this Agreement.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Development Data means all non-clinical, clinical, technical, chemical, safety, and scientific data and information and other results, including relevant laboratory notebook information, screening data, and synthesis schemes, including descriptions in any form, data and other information, in each case, that is generated by or resulting from or in connection with the conduct of Development of Products.

  • Pre-Licensed Therapist means an individual who has obtained a Master’s Degree in Social Work or Marriage and Family Therapy and is registered with the BBS as an Associate CSW or MFT Intern acquiring hours for licensing. An individual’s registration is subject to regulations adopted by the BBS.

  • Clinical Trial means any human clinical trial of a Product.

  • Field means all fields of use.

  • Collaborating physician means the physician who,

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).